(PDF) Second Allogeneic Stem-Cell Transplantation (SCT)

Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2012.11.279

Full Text

Open PDF

Abstract

Available in full text

Date

February 1, 2013

Authors

Publisher

Elsevier BV

Related search

Outcome of Allogeneic (Allo) Stem Cell Transplant (SCT) After Failure of a Prior SCT: A Single Center's Experience

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2009

English

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (ALLO-SCT) for Hodgkin's Lymphoma: A Single Institution Experience

Hematological Oncology

English

Severe Chronic Psychosis After Allogeneic SCT From a Schizophrenic Sibling

Bone Marrow Transplantation

Transplantation

Hematology

2014

English

Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed After Autograft: A Multicenter Retrospective Study Based on Donor Availability

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2012

English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology

Hematology

2010

English

Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

Outcome and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Haematopoietic SCT

Bone Marrow Transplantation

Transplantation

Hematology

2010

English

Long-Term Clinical and Molecular Remission After Allogeneic Stem Cell Transplantation (SCT) in Patients With Poor Prognosis Non-Hodgkin's Lymphoma

English

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

English

Amanote Research

Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2012.11.279

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Outcome of Allogeneic (Allo) Stem Cell Transplant (SCT) After Failure of a Prior SCT: A Single Center's Experience

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (ALLO-SCT) for Hodgkin's Lymphoma: A Single Institution Experience

Severe Chronic Psychosis After Allogeneic SCT From a Schizophrenic Sibling

Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed After Autograft: A Multicenter Retrospective Study Based on Donor Availability

Relapse After Allogeneic Stem Cell Transplantation

Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant

Outcome and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Haematopoietic SCT

Long-Term Clinical and Molecular Remission After Allogeneic Stem Cell Transplantation (SCT) in Patients With Poor Prognosis Non-Hodgkin's Lymphoma

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)